Finerenone Reduces Risk of Incident Heart Failure in Patients With Chronic Kidney Disease and Type 2 Diabetes: Analyses From the FIGARO-DKD Trial.

Circulation · 2022 · PMC8812430 · PMID 34775784

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

nominally significantno p-value reported

Results for the outcome of time to cardiovascular death or first HHF were not modified across key prespecified and post hoc subgroups, except for a nominally significant interaction for the SGLT-2i subgroup (Figure 3 ).

also in 7,732 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.